Row over SMA drug distribution in Keralam unwarranted, say experts
SAT Hospital authorities deny the claim of parents of SMA children that the drug given free of cost at the hospital clinic was an “experimental drug.” Hospital authorities say what was given was the generic version of Risdiplam, the patented original formula by Roche, now manufactured by the Indian firm Natco Pharma and which has been approved by drug regulatory bodies in the country
This is a preview. The full story is available on The Hindu.
Read Full Article on The Hindu

